Lloyds Banking Group’s Pfizer PFE Stock Holding History

Lloyds Banking Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$19K	Hold	468	–	–	0.27%	52
2018 Q3	$19K	Hold	468	–	–	0.23%	54
2018 Q2	$16K	Hold	468	–	–	0.13%	55
2018 Q1	$15K	Hold	468	–	–	0.12%	53
2017 Q4	$16K	Hold	468	–	–	0.15%	51
2017 Q3	$15K	Hold	468	–	–	0.15%	53
2017 Q2	$14K	Hold	468	–	–	0.14%	51
2017 Q1	$15K	Hold	468	–	–	0.14%	51
2016 Q4	$14K	Hold	468	–	–	0.12%	47
2016 Q3	$15K	Sell	468 -1,345	-74%	-$45K	0.13%	46
2016 Q2	$60K	Hold	1,813	–	–	0.49%	48
2016 Q1	$50K	Sell	1,813 -10,418	-85%	-$298K	0.41%	49
2015 Q4	$374K	Sell	12,231 -6,252	-34%	-$197K	3.03%	7
2015 Q3	$550K	Sell	18,483 -1,645	-8%	-$52.7K	4.07%	2
2015 Q2	$640K	Sell	20,128 -78,647	-80%	-$2.56M	4.1%	2
2015 Q1	$3.26M	Sell	98,775 -29,275	-23%	-$931K	8.33%	1
2014 Q4	$3.79M	Sell	128,050 -155,531	-55%	-$4.46M	7.29%	1
2014 Q3	$7.96M	Buy	283,581 +44,051	+18%	+$1.24M	2.17%	4
2014 Q2	$6.74M	Sell	239,530 -4,773,604	-95%	-$136M	1.63%	7
2014 Q1	$153M	Sell	5,013,134 -56,974	-1%	-$1.7M	1.36%	10
2013 Q4	$147M	Buy	5,070,108 +202,089	+4%	+$5.88M	1.33%	12
2013 Q3	$133M	Buy	4,868,019 +2,118,142	+77%	+$57.6M	1.36%	12
2013 Q2	$73.1M	Buy	+2,749,877	New	+$76M	0.77%	36

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lloyds Banking Group's PFE Position: Q4 2018 in Review

Lloyds Banking Group held its Pfizer (PFE) position steady in Q4 2018 at 468 shares worth $19K. The position accounts for 0.27% of the portfolio, ranked #52.

Lloyds Banking Group first reported a position in PFE in Q2 2013 and has held it in 23 quarters since. The position peaked at $153M in Q1 2014. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

Lloyds Banking Group held 468 shares of Pfizer worth $19K as of Q4 2018.
Lloyds Banking Group left its Pfizer share count unchanged in Q4 2018.
Pfizer made up 0.27% of Lloyds Banking Group's portfolio in Q4 2018, its #52 holding.
Lloyds Banking Group first reported a position in Pfizer in Q2 2013 and has held it in 23 quarters since.
Lloyds Banking Group's Pfizer position peaked at $153M in Q1 2014.
2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Lloyds Banking Group's 13F filing for Q4 2018, filed 11 Feb 2019.